Fulminant Epstein-Barr viral hepatitis: Orthotopic liver transplantation and review of the literature

Liver Transplantation and Surgery

Volumn 4, Issue 6, 1998, Pages 469-476

  Feranchak, A P ^a   Tyson, R W ^a   Narkewicz, M R ^a   Karrer, F M ^a   Sokol, R J ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0031763087     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040612     Document Type: Article

References (39)

1. 1 Sumaya C, Uch Y. Epstein‐Barr virus infectious mononucleosis in children: I. Clinical and general laboratory; II. Heterophil antibody and viral‐specific responses. Pediatrics 1985 ; 75: 1003–1019. MEDLINE
2. 2 Penman HG. Fatal infectious mononucleosis: A critical review. J Clin Pathol 1970 ; 23: 765–771. MEDLINE
3. 3 White NJ, Juel‐Jensen BE. Infectious mononucleosis hepatitis. Semin Liver Dis 1984 ; 4: 301–306. MEDLINE
4. 4 Markin RS. Manifestations of Epstein‐Barr virus–associated disorders in liver. Liver 1994 ; 14: 1–13. MEDLINE
5. 5 Markin RS, Linder J, Zuerlein K, Mroczek E, Grierson HL, Brichacek B, et al. Hepatitis in fatal infectious mononucleosis. Gastroenterology 1987 ; 93: 1210–1217. MEDLINE
6. 6 Allen UR, Bass BH. Fatal hepatic necrosis in glandular fever. J Clin Pathol 1963 ; 16: 337–341.
7. 7 McMahon JM, Elliott CW, Green RC. Infectious mononucleosis complicated by hepatic coma. Am J Gastroenterol 1969 ; 51: 200–207. MEDLINE
8. 8 Ainley NJ. A fatal case of infectious mononucleosis with extensive zonal necrosis of the liver. Ulster Med J 1949 ; 18: 219–221.
9. 9 Tazawa Y, Nishinomiya F, Noguchi H, Takada G, Tsuchiya S, Sumazaki R, et al. A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8‐positive lymphocyte infiltration in the liver. Human Pathol 1993 ; 24: 1135–1139.
10. 10 Iijima T, Sumazaki R, Mori N, Oka K, Nagai Y, Shibazaki M, et al. A pathological and immunohistological case report of fatal infectious mononucleosis, Epstein‐Barr virus infection, demonstrated by in situ and Southern blot hybridization. Virchows Arch A Pathol Anat 1992 ; 421: 73–78.
11. 11 Shaw NJ, Evans JHC. Liver failure and Epstein‐Barr virus infection. Arch Dis Child 1988 ; 63: 432–445. MEDLINE
12. 12 Harries JT, Ferguson AW. Fatal infectious mononucleosis with liver failure in two sisters. Arch Dis Child 1968 ; 43: 480–485. MEDLINE
13. 13 Rahal JJ, Henle G. Infectious mononucleosis and Reye's syndrome: A fatal case with studies for Epstein‐Barr virus. Pediatrics 1970 ; 46: 776–780. MEDLINE
14. 14 Chang MY, Campbell WG. Fatal infectious mononucleosis in association with liver necrosis and herpes‐like virus particles. Arch Pathol 1975 ; 99: 185–191. MEDLINE
15. 15 Jain S, Sherlock S. Infectious mononucleosis with jaundice, anaemia, and encephalopathy. BMJ 1975 ; 3: 138–139. MEDLINE
16. 16 Pelletier LL, Bores DM, Roning DA, Lin C. Disseminated intravascular coagulation and hepatic necrosis. Complications of infectious mononucleosis. JAMA 1976 ; 235: 1144–1146. MEDLINE
17. 17 Adkins BJ, Steele RH. Death from massive hepatic necrosis in infectious mononucleosis. N Z Med J 1977 ; 85: 56–58. MEDLINE
18. 18 Crawford DH, Epstein MA, Achong BG, Finerty S, Newman J, Liversedge S, et al. Virological and immunological studies on a fatal case of infectious mononucleosis. J Infect Dis 1979 ; 1: 37–48.
19. 19 Davies MH, Morgan‐Capner P, Portman B, Wilkinson SP, Williams R. A fatal case of Epstein‐Barr virus infection with jaundice and renal failure. Postgrad Med 1980 ; 56: 794–795.
20. 20 Hart GK, Thompson WR, Schneider J, Davis NJ. Fulminant hepatic failure and fatal encephalopathy associated with Epstein‐Barr virus infection. Med J Aust 1984 ; 141: 112–113. MEDLINE
21. 21 Coppoletta JM, Wolbach SB. Body length and organ weights of infants and children: Study of body length and normal weights of more important vital organs of body between birth and twelve years of age. Am J Pathol 1933 ; 9: 55–70.
22. 22 Zaia JA, Levin MJ. Cytomegalovirus immune globulin: Production from selected normal donor blood. Transplantation 1979 ; 27: 66–67. MEDLINE
23. 23 Weigle KA, Sumaya CV, Montiel MM. Changes in T‐lymphocyte subsets during childhood Epstein‐Barr virus infectious mononucleosis. J Clin Immunol 1983 ; 3: 151–155. MEDLINE
24. 24 Miller DJ, Dwyer JM, Klastskin G. T cells and the hepatitis of infectious mononucleosis [letter]. N Engl J Med 1976 ; 275: 450.
25. 25 Duffy LF, Daum F, Kahn E. Hepatitis in children with acquired immune deficiency syndrome. Gastroenterology 1986 ; 90: 173–181. MEDLINE
26. 26 Sullivan JL. Epstein‐Barr virus and the X‐linked lymphoproliferative syndrome. Adv Pediatr 1984 ; 30: 365–399.
27. 27 Hanto DW, Frizzera G, Gajl‐Peczalska KJ, Simmons RL. Epstein‐Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985 ; 39: 461–472. MEDLINE
28. 28 Stephanion E, Gruber SA, Dunn DL, Matas AJ. Posttransplant lymphoproliferative disorders. Transplant Rev 1991 ; 5: 120–129.
29. 29 Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein‐Barr virus serology and Epstein‐Barr virus‐associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993 ; 56: 1394–1398. MEDLINE
30. 30 Malatack JM, Gartner JC, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein‐Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern. J Pediatr 1991 ; 118: 667–675. MEDLINE
31. 31 Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault‐Keener MM, Storch GA. Epstein‐Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995 ; 60: 547–554. MEDLINE
32. 32 Bai X, Hosler G, Rogers BB, Dawson DB, Scheuermann RH. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein‐Barr virus burden in posttransplant lymphoproliferative disorder. Clin Chem 1997 ; 43: 1843–1849. MEDLINE
33. 33 Rowe DT, Qu L, Jabbour N, Yunis E, Putnam P, Todo S, et al. Use of quantitative competitive PCR to measure Epstein‐Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997 ; 35: 1612–1615. MEDLINE
34. 34 Hanto DW, Frizzera G, Gajl‐Peczalska KJ, Balfour HH, Simmons RL, Najarian JS. Acyclovir therapy of Epstein‐Barr virus–induced posttransplant lymphoproliferative diseases. Transplant Proc 1985 ; 17: 89–92.
35. 35 Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, et al. Reduced incidence of Epstein‐Barr virus–associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 1997 ; 64: 848–852. MEDLINE
36. 36 Manez R, Breinig MC, Linden P, Wilson J, Torre‐Cisneros J, Kusne S, et al. Posttransplant lymphoproliferative disease in primary Epstein‐Barr virus infection after liver transplantation: The role of cytomegalovirus disease. J Infect Dis 1997 ; 176: 1462–1467. MEDLINE
37. 37 Koskinen PK. The association of the induction of vascular cell adhesion molecule‐1 with cytomegalovirus antigenemia in human heart allografts. Transplantation 1993 ; 56: 1103–1108. MEDLINE
38. 38 Green M. Preemptive therapy: Epstein‐Barr virus. Transplant Proc 1996 ; 28: 5–6. MEDLINE
39. 39 Scheimann AO, Arumugam R, Reid BS, Soriano H, Gopalakrishna GS, Barakat O, et al. Cytomegalovirus hyperimmune globulin as adjunctive therapy for pediatric post‐transplant lymphoproliferative disease (PTLD) [abstract 858]. Hepatology 1997 ; 26: 343A.